SpectronRx
Radiopharmaceuticals CDMO & isotope producer
About
Founded to address critical shortages in medical isotopes, SpectronRx develops and manufactures therapeutic and diagnostic radiopharmaceuticals. The company operates as a contract development and manufacturing organization (CDMO/CMO) specializing in isotope production such as Ac-225. SpectronRx's business model focuses on expanding capacity and supply for oncology theranostics through advanced isotope manufacturing, serving clinical and research needs globally.
Products
-
Radiopharmaceutical CDMO/RDMO
— Contract development and manufacturing services for radiopharmaceuticals from early stage to commercialization.
Customer sectors: pharmaceutical companies, biotech developers, radiotherapy researchers
-
Isotope Production and Procurement
— Production and global sourcing of high-purity medical isotopes like Ac-225 for radiotherapy and diagnostics.
Customer sectors: nuclear medicine centers, radiopharmacies, research institutions
-
mAb, Nanobody and Peptide Labeling
— Radiolabeling of antibodies, nanobodies, and peptides with various isotopes for tracking and therapy.
Customer sectors: biotech researchers, clinical developers, radiotherapy labs
-
Worldwide Logistics
— Cold chain logistics ensuring secure, on-time delivery of radiopharmaceuticals globally at controlled temperatures.
Customer sectors: pharmaceutical distributors, clinical trial sponsors, treatment centers
-
Regulatory Assistance
— Regulatory consulting and management from early documentation to full FDA approval including IND filings.
Customer sectors: pharmaceutical developers, regulatory affairs teams, biotech startups
Market research & competitive positioning
Source-backed TAM / SAM / SOM sizing, displacement analysis, and an interactive peer positioning map for SpectronRx — available to members.
Related Companies
Other startups in Biotech & Therapeutics
